Gilead Sciences' Research Scholars Program funds early-career U.S. investigators pursuing innovative, independent HIV research to advance scientific understanding and address unmet needs in the field.
Funder: Gilead Sciences
Due Dates: June 25, 2026 (Research Scholars Program – U.S. HIV)
Funding Amounts: $180,000 per award (2 years, paid in annual installments; 4 awards expected)
Summary: Supports innovative, independent HIV research by early-career investigators in the U.S. to advance scientific understanding and address unmet needs.
Key Information: Applicants must be early-stage faculty, meet NIH ESI criteria, and not propose research on specific Gilead products.
The Research Scholars Program, funded by Gilead Sciences, aims to nurture the next generation of scientific leaders by supporting early-career, independent investigators engaged in high-impact HIV research in the United States. The program encourages novel approaches and diverse perspectives to address knowledge gaps and drive medical breakthroughs that improve patient outcomes. Emphasis is placed on supporting those who have not yet received substantial independent NIH funding and who demonstrate strong potential for future contributions to the field.